Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.

Saved in:
Bibliographic Details
Title: Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol.
Authors: van der Ploeg P; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Hendrikse CS; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Thijs AM; Department of Internal Medicine and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Smedts HP; Department of Obstetrics and Gynaecology, Amphia Hospital, Breda, the Netherlands., Vos MC; Department of Obstetrics and Gynaecology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Lok CA; Department of Gynaecologic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Boere IA; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands., van Ham MA; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands., Ottevanger PB; Department of Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Westermann AM; Department of Oncology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Mom CH; Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Lalisang RI; Department of Medical Oncology, Maastricht University Medical Centre +, Maastricht, the Netherlands., Lambrechts S; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre +, Maastricht, the Netherlands., Bekkers RL; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Piek JM; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.
Source: Heliyon [Heliyon] 2023 Dec 01; Vol. 10 (1), pp. e23170. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2405-8440
DOI:10.1016/j.heliyon.2023.e23170